financetom
Business
financetom
/
Business
/
Compass Pathways Insider Sold Shares Worth $704,821, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Compass Pathways Insider Sold Shares Worth $704,821, According to a Recent SEC Filing
Mar 15, 2024 4:52 AM

07:03 AM EDT, 03/15/2024 (MT Newswires) -- Ekaterina Malievskaia, 10% Owner, Director, around March 12, 2024, sold 65,886 shares in Compass Pathways ( CMPS ) for $704,821. Following the Form 4 filing with the SEC, Malievskaia has control over a total of 8,121,534 shares of the company, with 4,059,630 shares held directly and 4,061,904 shares controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1816590/000181659024000050/xslF345X03/wk-form4_1710464925.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Market Chatter: Jana Urges Wolfspeed to Explore Sale, Other Options
Update: Market Chatter: Jana Urges Wolfspeed to Explore Sale, Other Options
Apr 22, 2024
02:16 PM EDT, 04/22/2024 (MT Newswires) -- (Updates with additional information.) Activist investor Jana Partners urged Wolfspeed ( WOLF ) to explore ways to improve shareholder value, including a potential sale, Reuters reported Monday citing a letter it reviewed. The letter reportedly said that Goldman Sachs had assigned a $126 per share M&A price target to the company. Jana Partners...
Cherry Hill Mortgage Investment to Explore Strategic Options
Cherry Hill Mortgage Investment to Explore Strategic Options
Apr 22, 2024
02:23 PM EDT, 04/22/2024 (MT Newswires) -- Cherry Hill Mortgage Investment ( CHMI ) said Monday its board has formed a special committee to explore strategic options, including a merger or sale, to maximize shareholder value. There can be no assurance that this will lead to any transaction, the company said. Shares of the company were up nearly 7% in...
Why Is Liver-Disease Drug Developer Hepion Pharmaceuticals Stock Trading Lower On Monday?
Why Is Liver-Disease Drug Developer Hepion Pharmaceuticals Stock Trading Lower On Monday?
Apr 22, 2024
Friday, Hepion Pharmaceuticals Inc. ( HEPA ) said it has begun winding down activities in its ASCEND-NASH Trial while continuing to explore strategic alternatives, as announced in December 2023. ASCEND-NASH is a Phase 2b, randomized, multicenter, double-blinded study with the first patient screened in August 2022 to evaluate the safety and efficacy of rencofilstat dosed for 12 months, with a target enrollment of 336...
Market Chatter: Honda Motor Nears Deal for Canadian EV Production Facilities, Batteries, Bloomberg Reports
Market Chatter: Honda Motor Nears Deal for Canadian EV Production Facilities, Batteries, Bloomberg Reports
Apr 22, 2024
02:02 PM EDT, 04/22/2024 (MT Newswires) -- Honda Motor Company ( HMC ) is near a deal with the Canadian government to build electric vehicles and batteries in Ontario, Bloomberg News reported, citing people familiar with the matter. The news service said Canada will subsidize a portion of the capital costs for new facilities to process cathode active materials, build...
Copyright 2023-2026 - www.financetom.com All Rights Reserved